How to protect the proximal bronchial tree during stereotactic radiotherapy of ultracentral lung tumors: Lessons from MR-guided treatment

Both intrafractional breathing motion and interfractional translations may impact doses to the PBT during SBRT of ULT. SMART protects the PBT from overdoses while maintaining high PTV coverage. Non-adaptive SBRT appears safe with advanced breathing motion management and PRV, but yields inferior PTV coverage.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Radiation Oncology
Published
2024-12-07
DOI
https://doi.org/10.1016/j.ctro.2024.100899
Citations
2
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How to protect the proximal bronchial tree during stereotactic radiotherapy of ultracentral lung tumors: Lessons from MR-guided treatment

C. Katharina Renkamp, Marietta Kirchner, Sebastian Regnery, Matthias Gückenberger et al.
2 citations
Clinical and Translational Radiation Oncology
Lung Cancer Diagnosis and Treatment
0.84
article

How to protect the proximal bronchial tree during stereotactic radiotherapy of ultracentral lung tumors: Lessons from MR-guided treatment

C. Katharina Renkamp, Marietta Kirchner, Sebastian Regnery, Matthias Gückenberger, Jan Meis, Fabian Schlüter, Sebastian Klüter, Nicolaus Andratschke, Carolin Rippke, Juliane Hörner‐Rieber, Jürgen Debus, Fabian Weykamp, Efthimios Katsigiannopulos, Philipp Hoegen-Saßmannshausen, Alexandra Balzer, Hin Lau, Sophia Albert
article en
2 citations

Abstract

Both intrafractional breathing motion and interfractional translations may impact doses to the PBT during SBRT of ULT. SMART protects the PBT from overdoses while maintaining high PTV coverage. Non-adaptive SBRT appears safe with advanced breathing motion management and PRV, but yields inferior PTV coverage.

Clinical and Translational Radiation OncologyVol. 51
Zimmer Biomet (Netherlands) (NL), German Cancer Research Center (DE), University of Zurich (CH), Heidelberg University (DE), University Hospital Heidelberg (DE), Düsseldorf University Hospital (DE), University Hospital of Zurich (CH), Heidelberger Institut für Radioonkologie (DE), National Center for Tumor Diseases (DE), Heinrich Heine University Düsseldorf (DE)
Pfizer, AstraZeneca, Varian Medical Systems, Elekta, Novocure, Accuray, ViewRay, Deutsche Forschungsgemeinschaft, Siemens Healthineers, Army Research Office
Good health and well-being
Openalex Percentile: Top 22%
Lung Cancer Diagnosis and Treatment
0.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.